Skip to main content

Table 3 Univariate analysis of neutrophil count, lymphocyte count and NLR at each time point

From: Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy

 

Neutrophil count

Lymphocyte count

NLR

HR

95% CI

p

HR

95% CI

p

HR

95% CI

p

Overall nadir (n = 196)

 Overall survival

1.27

1.09–1.47

<0.01

1.60

0.93–2.76

0.09

1.01

0.98–1.05

0.51

 Cancer-specific survival

1.14

0.99–1.31

0.07

0.86

0.45–1.62

0.63

1.01

0.98–1.04

0.50

 Local control

1.23

1.04–1.46

0.02

1.53

0.83–2.83

0.18

1.00

0.95–1.05

0.92

 Distant control

1.18

0.95–1.49

0.14

0.38

0.08–1.75

0.21

1.05

1.01–1.10

0.01

Pre treatment (n = 194)

 Overall survival

1.21

1.02–1.44

0.03

1.03

0.68–1.55

0.89

1.07

1.01–1.14

0.02

 Cancer-specific survival

1.22

1.05–1.41

<0.01

1.18

0.85–1.63

0.33

1.04

0.98–1.11

0.17

 Local control

1.16

0.95–1.42

0.15

1.41

0.97–2.05

0.07

1.05

0.96–1.14

0.31

 Distant control

1.37

1.09–1.47

<0.01

1.45

0.95–2.21

0.09

1.00

0.89–1.13

1.00

Post treatment (n = 136)

 Overall survival

1.29

1.06–1.56

0.01

1.10

0.36–3.35

0.87

1.03

0.98–1.08

0.31

 Cancer-specific survival

1.25

0.99–1.57

0.06

0.47

0.12–1.89

0.29

1.04

0.99–1.10

0.10

 Local control

1.47

1.16–1.86

<0.01

1.42

0.39–5.12

0.60

1.04

0.99–1.09

0.17

 Distant control

1.18

0.88–1.57

0.27

1.65

0.47–5.81

0.44

0.98

0.91–1.06

0.67